Prof. Quan-Yang Duh: the increasing morbidity of PTMC in America may be resulted from overtreatment
The 2017 Annual Congress of International Society of Oncoplastic Endocrine Surgeons (ISOPES) was successfully held during April 20–23 in Hangzhou, China. Many renowned surgeons, abroad and at home attended this congress, presenting their personal clinical experience and sharing the state of art in endocrine surgery field.
During the congress, the editorial office of Annals of Thyroid (AOT) is honored to get a chance to interview Prof. Quan-Yang Duh from University of California, San Francisco, USA (Figure 1). According to Prof. Duh, there is a dramatically increasing morbidity of papillary thyroid microcarcinoma (PTMC) in the USA, which may be caused by the overtreatment. Currently we may do too much to the patients. When it came to early diagnosis, Prof. Duh said the problem was that we diagnosed the cancer too early and treat too early, as many small cancers didn’t actually grow to be clinical cancers. For the part of PTMC to be treated, surgery still plays a key role. While in the USA, which of the three non-traditional thyroid surgery, endoscopy, robot, and remote is more popular? Welcome to watch the video to get more Prof. Duh’s opinions (Figure 2).
Interview questions
- In your speech, you talked about PTMC in United States. What’s the morbidity of PTMC in United States?
- Any possibility to early diagnose it?
- Can you share with us the major treatments in United States?
- Among the three non-traditional thyroid surgery, endoscopy, robot, and remote, which one is more popular in United States?
- Is there any promising surgical treatment for thyroid cancer?
Expert introduction
Dr. Quan-Yang Duh is Professor and Chief of Endocrine Surgery and Associate Director of Advanced Videoscopic Surgery Center at UCSF. He is an attending surgeon at both UCSF Medical Center and San Francisco VA Medical Center. Dr. Duh specializes in surgery to treat tumors of the thyroid, parathyroid and adrenal glands, as well as endocrine and gastrointestinal malignancies. He is nationally and internationally recognized for his expertise in complex minimally invasive procedures including laparoscopic adrenalectomy, thyroidectomy, parathyroidectomy and hernia repair.
Dr. Duh graduated from Yale University, New Haven, CT, USA, with a BS in Molecular Biophysics and Biochemistry. He completed his surgical internship, residency and postdoctoral fellowship at the University of California, San Francisco, USA. He is the past president of the American Association of Endocrine Surgeons and the San Francisco Surgical Society, as well as president of the American College of Surgeons’ Northern California Chapter. Highly respected by his peers, Dr. Duh was named to the list of US News “America’s Top Doctors”, a distinction reserved for the top 1% of physicians in the nation for a given specialty.
Acknowledgments
Funding: None.
Footnote
Provenance and Peer Review: This article was commissioned by the editorial office, Annals of Thyroid for the series “Meet the Professor”. The article did not undergo external peer review.
Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/aot.2017.05.03). The series “Meet the Professor” was commissioned by the editorial office without any funding or sponsorship. The author reports that she is a full-time employee of AME Publishing Company. The author has no other conflicts of interest to declare.
Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Wang M. Prof. Quan-Yang Duh: the increasing morbidity of PTMC in America may be resulted from overtreatment. Asvide 2017;4:239. Available online: http://www.asvide.com/articles/1548
(Science Editor: Molly Wang, AOT, aot@amegroups.com)
Cite this article as: Wang M. Prof. Quan-Yang Duh: the increasing morbidity of PTMC in America may be resulted from overtreatment. Ann Thyroid 2017;2:2.
